Sponsor:
Insmed Incorporated
Code:
NCT07179380
Conditions
Pulmonary Hypertension
Interstitial Lung Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Treprostinil Palmitil Inhalation Powder
Placebo
Brief summary:
Conditions
Pulmonary Hypertension
Interstitial Lung Disease
Study ID
NCT07179380
Start date
Jan 7, 2026
Status verified date
Oct, 2026
Completion date
Dec 30, 2028
Anticipated
Primary completion date
Dec 30, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
344 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Treprostinil Palmitil Inhalation Powder
placebo comparator: Placebo
Interventions
Treprostinil Palmitil Inhalation Powder
Placebo
Primary outcome measure
Central contacts
Locations
USA010
Recruiting
Los Angeles, California, United States, 900275969
USA023
Recruiting
Los Angeles, California, United States, 90095
USA020
Recruiting
San Francisco, California, United States, 94143
USA001
Recruiting
Santa Barbara, California, United States, 93105-4349
USA017
Recruiting
Gainesville, Florida, United States, 32610
USA006
Recruiting
Naples, Florida, United States, 34102-5412
USA026
Recruiting
St. Petersburg, Florida, United States, 33707-6129
USA002
Recruiting
Kansas City, Kansas, United States, 66160
USA005
Recruiting
New York, New York, United States, 10016
USA011
Recruiting
Durham, North Carolina, United States, 27710
USA015
Recruiting
Cincinnati, Ohio, United States, 45267
USA003
Recruiting
Bend, Oregon, United States, 97701
USA013
Recruiting
Philadelphia, Pennsylvania, United States, 19140
USA008
Recruiting
Richmond, Virginia, United States, 23230
Sponsor
Insmed Incorporated
Last update posted
Oct 26, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Insmed Incorporated on 2026-10-26. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.